8-KEarnings & ResultsExhibits & Filings

VERTEX PHARMACEUTICALS INC / MA 8-K Report, Financial Results (Oct 25, 2010)

Filed October 25, 2010For Securities:VRTX

Summary

Vertex Pharmaceuticals Inc. (VRTX) filed a Form 8-K on October 25, 2010, to report its consolidated financial results for the quarter ended September 30, 2010. This filing primarily serves to attach a press release detailing these financial results. While the 8-K itself does not contain the specific financial figures, it directs investors to Exhibit 99.1, the press release, for a comprehensive overview of the company's performance during the third quarter of 2010. Investors should review the referenced press release for details on revenue, net income, earnings per share, and any significant operational updates or business developments that occurred during the period. The filing serves as official notification of the release of this important financial information, signaling Vertex's ongoing commitment to timely disclosure.

Key Highlights

  • 1Vertex Pharmaceuticals filed an 8-K on October 25, 2010.
  • 2The filing is to report consolidated financial results for the quarter ended September 30, 2010.
  • 3The detailed financial results are provided in an attached press release (Exhibit 99.1).
  • 4The press release is incorporated by reference into the 8-K.
  • 5This filing confirms the public release of Q3 2010 financial performance data.
  • 6The filing does not contain specific financial numbers but points to the press release for them.

Frequently Asked Questions

The primary purpose of this Form 8-K filing is to officially report Vertex Pharmaceuticals' consolidated financial results for the fiscal quarter ended September 30, 2010. It serves as a notification that this information has been made public.

The actual financial results for the quarter ended September 30, 2010, are detailed in the press release attached to this 8-K as Exhibit 99.1. Investors should refer to this press release for specific figures regarding revenue, earnings, and other financial metrics.

According to the filing, the information set forth in Exhibit 99.1 (the press release) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liability of that section, unless expressly incorporated by reference into another filing.

This filing is significant as it marks the official public disclosure of Vertex's financial performance for the third quarter of 2010. It provides investors with timely information to assess the company's operational and financial health during that period.